Instrument to quantify solution binding kinetics for drug discovery & development

用于药物发现的溶液结合动力学量化仪器

• 批准号: 7794532
• 负责人: JENNIFER A MAYNARD
• 金额: $ 17.13万
• 依托单位: UNIVERSITY OF TEXAS AT AUSTIN
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-20 至 2011-05-19
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7794532
• 关键词: Address; Area; Binding; Biological; Biological Phenomena; Carcinogenesis Mechanism; Communities; Complex; Core Facility; Data; Development; Disease; Dissociation; Equilibrium; Equipment; Funding; Health; Human; Institutes; Institution; Kinetics; Ligands; Measures; Minor; Molecular and Cellular Biology; Policies; Protein Binding; Proteins; Research; Solutions; Technology; Texas; Universities; austin; college; drug discovery; human disease; instrument; interest; novel therapeutics; public health relevance; rapid technique; small molecule; therapy development; water quality

DESCRIPTION (provided by applicant): We are requesting funds to purchase an instrument (KinExA) with the ability to sensitively and precisely measure binding kinetics from the millimolar to picomolar ranges and to quantify femptomolar concentrations of molecules of interest in complex solutions. These instruments will be used to identify, quantify and characterize small molecules and proteins that bind to biological targets of interest, which can then serve as starting points for drug discovery and development. There are no machines with the same capabilities available at the University of Texas at Austin or nearby campuses. UT does have one BIAcore 3000, able to measure binding kinetics to an immobilized ligand with less sensitivity, which is highly valued and receives very heavy use, such that it is practically unavailable to most users. The protein core facility owns a BIAcore 1000 which is available to most users, but has outlived its useful lifetime (produced circa 1990) and no longer produces reliable data. Regardless, these BIAcore machines do not possess several key desired capabilities: the ability to measure binding kinetics in solution, the ability to measure equilibrium dissociation constants as low as picomolar or as high as millimolar, or the ability to measure concentrations of molecules of interest when present at parts per trillion concentrations. The addition of a KinExA would therefore serve a unique purpose at UT Austin. The new equipment would be placed in the Institute for Molecular and Cellular Biology (ICMB) Protein Core Facility at UT and be available to the entire UT community. The ICMB has already established the space, staff, and recharge policies to maintain this equipment. The purchase of this instrument has broad support; the major and minor users listed in this proposal come from two institutions, three colleges and six departments, and their collective research interests address three NIH-funded themes: (1) drug discovery and development, (2) effects of water quality on human health and (3) basic mechanisms of carcinogenesis. Addition of these instruments will introduce radically new capabilities at the UT campus for drug discovery technologies and developing therapies in a variety of disease areas. PUBLIC HEALTH RELEVANCE: The KinExA instrument for which we are requesting funds represents a new, highly sensitive and rapid method for identifying and measuring the concentration of molecules with biological activity. These molecules can be used to interrogate basic biological phenomena or comprise new therapeutics for a wide variety of human diseases.

描述（由申请人提供）：我们正在申请资金购买一种仪器（KinExA），该仪器能够灵敏和精确地测量从毫摩尔到皮摩尔范围的结合动力学，并量化复杂溶液中感兴趣的分子的毫摩尔浓度。这些仪器将用于识别、量化和表征与感兴趣的生物靶点结合的小分子和蛋白质，然后可以作为药物发现和开发的起点。在德克萨斯大学奥斯汀分校（University of Texas at Austin）或附近的校园里，没有具备相同功能的机器。UT确实有一个BIAcore 3000，能够以较低的灵敏度测量固定配体的结合动力学，这是非常有价值的，并且得到了非常大量的使用，以至于大多数用户实际上无法使用它。蛋白质核心设施拥有BIAcore 1000，大多数用户都可以使用，但已超过其使用寿命（大约在1990年生产），不再产生可靠的数据。无论如何，这些BIAcore机器不具备几个关键的期望功能：测量溶液中的结合动力学的能力，测量低至皮摩尔或高至毫摩尔的平衡解离常数的能力，或测量以万亿分之一浓度存在的感兴趣分子的浓度的能力。因此，KinExA的增加将在德州大学奥斯汀分校起到独特的作用。新设备将放置在UT分子和细胞生物学研究所（ICMB）蛋白质核心设施中，并可供整个UT社区使用。ICMB已经建立了维护这些设备的空间、人员和充值政策。购买本仪器有广泛的支持；本提案中列出的主要和次要用户来自两个机构，三个学院和六个部门，他们的集体研究兴趣涉及nih资助的三个主题：(1)药物发现和开发；(2)水质对人类健康的影响；(3)致癌的基本机制。这些仪器的加入将为德州大学校园的药物发现技术和开发各种疾病领域的治疗方法带来全新的能力。

项目成果

Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin.

中和博德特氏菌腺苷酸环化酶毒素的两种抗体的精细表位作图。

• DOI: 10.1021/acs.biochem.6b01163
• 发表时间: 2017
• 期刊: Biochemistry
• 影响因子: 2.9
• 作者: Wang,Xianzhe;Stapleton,JamesA;Klesmith,JustinR;Hewlett,ErikL;Whitehead,TimothyA;Maynard,JenniferA
• 通讯作者: Maynard,JenniferA